Method of treating a patient having precancerous lesions with quinazoline derivatives
申请人:Cell Pathways, Inc.
公开号:US06262059B1
公开(公告)日:2001-07-17
Derivatives of Quinazoline are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.